NIH toughens ethics rules and procedures

Guest Contributor
June 30, 2004

The US National Institutes of Health (NIH) is considering drastic changes to its rules and procedures for ethics following the disclosure of high level NIH-funded scientists receiving consulting fees and stock options from biotechnology and pharmaceutical companies. NIH director Dr Elias Zerhouni recently appeared before a congressional committee examining the NIH’s lax ethics regulations and outlined a series of corrective measures. These include prohibiting senior NIH employees involved in extramural funding decisions from entering paid consulting agreements with industry and accepting payment in the form of stock or stock options....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.